Wave Life Sciences Ltd.

DB:1U5 Stock Report

Market Cap: €985.0m

Wave Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:1U5 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Mar 26Buy€47,692,544RA Capital Management, L.P.Company8,772,496€5.68
30 Mar 26Buy€47,692,544RA Capital Management, L.P.Company8,772,496€5.68
09 Feb 26Sell€21,279Christopher FrancisIndividual1,883€11.30
09 Feb 26Sell€36,479Chandra VargeeseIndividual3,228€11.30
09 Feb 26Sell€118,431Paul B. BolnoIndividual10,480€11.30
09 Feb 26Sell€40,547Kyle B. MoranIndividual3,588€11.30
11 Dec 25Buy€23,762,844GSK Equity Investments, LimitedCompany1,470,000€16.17
08 Dec 25Sell€179,011Aik Na TanIndividual14,988€12.91
13 Nov 25Buy€5,745RA Capital Management, L.P.Company1,000€5.74
13 Nov 25Buy€5,745RA Capital Management, L.P.Company1,000€5.74

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1U5?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders729,7470.379%
General Public8,070,1144.19%
Public Companies9,606,4084.99%
Hedge Funds10,161,3995.28%
VC/PE Firms45,221,19623.5%
Institutions118,613,33861.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.8%.

Top Shareholders

Top 25 shareholders own 75.55% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14%
RA Capital Management, L.P.
26,975,505€138.1m0%1.91%
9.48%
GSK Equity Investments, Limited
18,245,691€93.4m0%11.07%
7.34%
BlackRock, Inc.
14,117,374€72.3m11.6%no data
5.28%
Maverick Capital, Ltd.
10,161,399€52.0m9.5%0.6%
4.99%
Shin Nippon Biomedical Laboratories, Ltd.
9,606,408€49.2m0%no data
4.52%
T. Rowe Price Group, Inc.
8,704,550€44.6m17.5%no data
2.82%
Driehaus Capital Management LLC
5,431,021€27.8m-17.5%0.14%
2.76%
Federated Hermes, Inc.
5,317,457€27.2m12.1%0.05%
2.7%
FMR LLC
5,192,690€26.6m-65.7%no data
2.55%
683 Capital Management, LLC
4,900,000€25.1m22%2.55%
2.51%
PRIMECAP Management Company
4,832,952€24.7m18%0.02%
2.38%
M28 Capital Management LP
4,588,284€23.5m-19%57.41%
1.91%
State Street Global Advisors, Inc.
3,674,033€18.8m22.6%no data
1.86%
Geode Capital Management, LLC
3,579,099€18.3m12.9%no data
1.27%
Artal Group S.A.
2,450,000€12.5m0%0.28%
1.14%
Citadel Advisors LLC
2,202,856€11.3m179%0.01%
1.08%
Emerald Advisers, LLC
2,075,712€10.6m-46.4%0.19%
0.98%
Two Sigma Investments, LP
1,878,115€9.6m151%0.01%
0.97%
Pfizer Venture Investments LLC
1,875,000€9.6m0%4.81%
0.96%
First Light Asset Management, LLC
1,843,968€9.4m-0.53%0.82%
0.93%
Marshall Wace LLP
1,789,882€9.2m0%0.01%
0.84%
Vanguard Capital Management, LLC
1,611,853€8.3m0%no data
0.76%
Squarepoint OPS LLC
1,462,390€7.5m65.5%0.02%
0.75%
Schroder Investment Management Limited
1,441,059€7.4m43.3%no data
0.73%
Affinity Asset Advisors, LLC
1,401,727€7.2m-48.1%0.52%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/28 09:46
End of Day Share Price 2026/06/26 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Wave Life Sciences Ltd. is covered by 28 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alec StranahanBofA Global Research
Madison Wynne El-SaadiB. Riley Securities, Inc.
Whitney IjemCanaccord Genuity